From RT-qPCR results, with the increase of glioma grade, the expression of IL-6 in glioma clinical samples showed a downward trend, while expression of EZH2, IL-8, and MIP-3α exhibited an upward trend (Figures 1E–H). This evidence concerns the gene IL6 and central nervous system cancer.